J Neurol Surg Rep 2014; 75(01): e62-e66
DOI: 10.1055/s-0033-1363505
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Primary Neurolymphomatosis of the Lower Cranial Nerves Presenting as Dysphagia and Hoarseness: A Case Report

Naoto Sakai
1   Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, Higashiku, Hamamatsu, Japan
,
Tae Ito-Yamashita
1   Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, Higashiku, Hamamatsu, Japan
,
Goro Takahashi
2   Department of Otolaryngology, Hamamatsu University School of Medicine, Handayama, Higashiku, Hamamatsu, Japan
,
Satoshi Baba
3   Department of Diagnostic Pathology, Hamamatsu University School of Medicine, Handayama, Higashiku, Hamamatsu, Japan
,
Shinichiro Koizumi
1   Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, Higashiku, Hamamatsu, Japan
,
Tomohiro Yamasaki
1   Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, Higashiku, Hamamatsu, Japan
,
Tsutomu Tokuyama
1   Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, Higashiku, Hamamatsu, Japan
,
Hiroki Namba
1   Department of Neurosurgery, Hamamatsu University School of Medicine, Handayama, Higashiku, Hamamatsu, Japan
› Author Affiliations
Further Information

Publication History

29 December 2012

03 November 2013

Publication Date:
16 January 2014 (online)

Abstract

Primary neurolymphomatosis is an extremely rare tumor. We report the case of a 74-year-old patient presenting with dysphagia and hoarseness. Initial contrast-enhanced computed tomography of the head, neck, and chest did not reveal any lesions. His symptoms improved with short-term administration of prednisone but recurred and deteriorated. Magnetic resonance (MR) imaging revealed a tumor along the ninth and tenth cranial nerves across the jugular foramen. Fluorine-18 fluorodeoxyglucose positron emission tomography indicated this was a primary tumor. Repeated MR imaging after 2 months revealed considerable tumor enlargement. A left suboccipital craniotomy was performed to remove the tumor that infiltrated the ninth and tenth cranial nerves. The histopathologic diagnosis was diffuse large B-cell lymphoma. Although focal radiation therapy was administered to ensure complete eradication of the tumor, the patient died of aspiration pneumonia with systemic metastasis. To our knowledge, this is the first reported case of primary neurolymphomatosis in the lower cranial nerves.

 
  • References

  • 1 Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH. Neurolymphomatosis. Neuro Oncol 2003; 5 (2) 104-115
  • 2 Grisariu S, Avni B, Batchelor TT , et al; International Primary CNS Lymphoma Collaborative Group. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 2010; 115 (24) 5005-5011
  • 3 Kim JH, Jang JH, Koh SB. A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings. J Neurooncol 2006; 80 (2) 209-210
  • 4 Santos E, Scolding NJ. Neurolymphomatosis mimicking neurosarcoidosis: a case report. J Med Case Reports 2010; 4: 5
  • 5 Hung MH, Gau JP. Relapsed testicular lymphoma presenting with cranial nerve neurolymphomatosis. Neurology 2011; 76 (16) 1441
  • 6 Iplikcioglu AC, Dinc C, Bikmaz K, Ozcan D. Primary lymphoma of the trigeminal nerve. Br J Neurosurg 2006; 20 (2) 103-105
  • 7 Levin N, Soffer D, Grissaru S, Aizikovich N, Gomori JM, Siegal T. Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neurooncol 2008; 90 (1) 77-83
  • 8 Gan HK, Azad A, Cher L, Mitchell PL. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro Oncol 2010; 12 (2) 212-215
  • 9 Epelbaum R, Haim N, Ben-Shahar M, Ben-Arie Y, Feinsod M, Cohen Y. Non-Hodgkin's lymphoma presenting with spinal epidural involvement. Cancer 1986; 58 (9) 2120-2124
  • 10 Barajas Jr RF, Rubenstein JL, Chang JS, Hwang J, Cha S. Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 2010; 31 (1) 60-66
  • 11 Ennishi D, Yokoyama M, Terui Y , et al. Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy. Ann Oncol 2009; 20 (3) 526-533
  • 12 Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992; 159 (3) 591-599
  • 13 Rowley HA, Grant PE, Roberts TP. Diffusion MR imaging. Theory and applications. Neuroimaging Clin N Am 1999; 9 (2) 343-361
  • 14 Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002; 224 (1) 177-183
  • 15 Stadnik TW, Chaskis C, Michotte A , et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 2001; 22 (5) 969-976
  • 16 Takeshita T, Asao H, Ohtani K , et al. Cloning of the gamma chain of the human IL-2 receptor. Science 1992; 257 (5068) 379-382